| HUMAN-TRIAL | evidence | A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity | Semaglutide | Weight & fat loss · human-rct · n = 201 | — |
| HUMAN-TRIAL | evidence | A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 87 | — |
| HUMAN-TRIAL | evidence | A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India | Semaglutide | Glycemic control · human-observational · n = 388 | — |
| HUMAN-TRIAL | evidence | Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects | Semaglutide | Glycemic control · human-rct · n = 78 | — |
| HUMAN-TRIAL | evidence | Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis | Semaglutide | Glycemic control · human-rct · n = 100 | — |
| HUMAN-TRIAL | evidence | Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes | Semaglutide | Weight & fat loss · human-rct · n = 20 | — |
| HUMAN-TRIAL | evidence | Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity | Semaglutide | Weight & fat loss · human-rct · n = 1210 | — |
| HUMAN-TRIAL | evidence | STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss | Semaglutide | Weight & fat loss · n = 500 | — |
| HUMAN-TRIAL | evidence | Exercise and GLP-1 RA on Insulin Secretion | Semaglutide | Glycemic control · human-rct · n = 30 | — |
| HUMAN-TRIAL | evidence | Sleeve Gastrectomy vs. Lifestyle & Medications: Impact on BMI Trajectory and Target Attainment in a Matched Cohort Study | Semaglutide | Weight & fat loss · human-observational · n = 190 | — |
| HUMAN-TRIAL | evidence | A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes | Semaglutide | Glycemic control · n = 148 | — |
| HUMAN-TRIAL | evidence | A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) | Semaglutide | Weight & fat loss · human-rct · n = 120 | — |
| HUMAN-TRIAL | evidence | Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant | Wegovy | human-rct · n = 50 | — |
| HUMAN-TRIAL | evidence | Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes | Ozempic | Glycemic control · human-rct · n = 252 | — |
| HUMAN-TRIAL | evidence | Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. | Semaglutide | Weight & fat loss · human-rct · n = 62 | — |
| HUMAN-TRIAL | evidence | Semaglutide Treatment for Hyperglycaemia After Renal Transplantation | Rybelsus | Glycemic control · human-rct · n = 104 | — |
| HUMAN-TRIAL | evidence | A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice | Semaglutide | Glycemic control · human-observational · n = 187 | — |
| HUMAN-TRIAL | evidence | Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only | Semaglutide | Glycemic control · human-rct · n = 703 | — |
| HUMAN-TRIAL | evidence | Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin | Semaglutide | Glycemic control · human-rct · n = 731 | — |
| HUMAN-TRIAL | evidence | Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes | Semaglutide | Glycemic control · human-observational · n = 400 | — |
| HUMAN-TRIAL | evidence | The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy | Semaglutide | Glycemic control · human-rct · n = 50 | — |
| HUMAN-TRIAL | evidence | Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range | Semaglutide | Weight & fat loss · human-rct · n = 307 | — |
| HUMAN-TRIAL | evidence | Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction | Semaglutide | Glycemic control · human-observational · n = 28118 | — |
| HUMAN-TRIAL | evidence | Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women | Semaglutide | Weight & fat loss · human-rct · n = 30 | — |
| HUMAN-TRIAL | evidence | Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects | Semaglutide | Glycemic control · human-rct · n = 96 | — |
| HUMAN-TRIAL | evidence | Feasibility of Semaglutide in Advanced Lung Disease | Ozempic | Weight & fat loss · n = 8 | — |
| HUMAN-TRIAL | evidence | Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt | Wegovy | Weight & fat loss · human-rct · n = 168 | — |
| HUMAN-TRIAL | evidence | Lifestyle Counseling and Medication for Adolescent Weight Management | Semaglutide | Weight & fat loss · human-rct · n = 120 | — |
| HUMAN-TRIAL | evidence | A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight | Semaglutide | human-rct · n = 2500 | — |
| HUMAN-TRIAL | evidence | Incretin Microdosing for Cardiometabolic Health in People With HIV | Semaglutide | human-rct · n = 30 | — |
| HUMAN-TRIAL | evidence | A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) | Semaglutide | Cognition & memory · human-rct · n = 1840 | — |
| HUMAN-TRIAL | evidence | First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes | Semaglutide | Weight & fat loss · human-rct · n = 152 | — |
| HUMAN-TRIAL | evidence | Semaglutide Treatment in Type 1 Diabetes | Semaglutide | human-rct · n = 122 | — |
| HUMAN-TRIAL | evidence | Epicardial Cardiac Fat-CT (EPIC-CT) | Rybelsus | human-rct · n = 136 | — |
| HUMAN-TRIAL | evidence | Prevention of Progression of Prediabetes, Obesity and CV Risk | Rybelsus | human-rct · n = 64 | — |
| HUMAN-TRIAL | evidence | Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea | Ozempic | Glycemic control · human-observational · n = 600 | — |
| HUMAN-TRIAL | evidence | Treatment of GLP-1 for Diabetic Bariatric Patients | Semaglutide | Glycemic control · human-rct · n = 3 | — |
| HUMAN-TRIAL | evidence | A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 1441 | — |
| HUMAN-TRIAL | evidence | Novel Therapeutics and Endothelial Dysfunction in T1DM Patients | Ozempic | Glycemic control · human-rct · n = 90 | — |
| HUMAN-TRIAL | evidence | Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes | Semaglutide | Glycemic control · human-rct · n = 158 | — |
| HUMAN-TRIAL | evidence | Oral Semaglutide in Patients With Alzheimer's Disease | Rybelsus | Cognition & memory · human-rct · n = 60 | — |
| HUMAN-TRIAL | evidence | A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide | NN9535 | Glycemic control · human-rct · n = 415 | — |
| HUMAN-TRIAL | evidence | A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term | Semaglutide | Weight & fat loss · human-rct · n = 609 | — |
| HUMAN-TRIAL | evidence | Comparison of Body Composition Changes With Weight Loss Interventions | Semaglutide | Weight & fat loss · human-observational · n = 60 | — |
| HUMAN-TRIAL | evidence | Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus | Semaglutide | Glycemic control · human-rct · n = 302 | — |
| HUMAN-TRIAL | evidence | A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV | Semaglutide | Glycemic control · human-rct · n = 90 | — |
| HUMAN-TRIAL | evidence | Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2) | Semaglutide | Glycemic control · human-rct · n = 956 | — |
| HUMAN-TRIAL | evidence | Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL) | Semaglutide | human-observational · n = 25664 | — |
| HUMAN-TRIAL | evidence | A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea | Wegovy | Weight & fat loss · human-observational · n = 840 | — |
| HUMAN-TRIAL | evidence | Special Use - Results Surveillance on Long-term Use With Wegovy® | Wegovy | Weight & fat loss · human-observational · n = 1071 | — |